Tags: Add Tags
  1. anonymous

    anonymous Guest

    Anyone want to comment on culture etc. The fact that they don't have their own designated thread on here is probably a positive. Contacted re Muscular Dystrophy position.
     

  2. anonymous

    anonymous Guest

    Cones is a tool and redneck. No culture. Or they spell it Kulture.
     
  3. anonymous

    anonymous Guest

    Ultra rare disease. Black box warning. Competitor due out shortly. Gonna be a rough ride.
     
  4. anonymous

    anonymous Guest


    Keep dumping samples flunky. No issues here. Only cash.
     
  5. anonymous

    anonymous Guest

    No box warning. Competitor PDUFA date not even set yet. Date for BioMarin drug set in December.
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    who contacted you re BioMarin
     
  8. anonymous

    anonymous Guest

    Does anyone know if they are recruiting for a new MSL team for product launch?
     
  9. anonymous

    anonymous Guest

    Okay, so will have a black box warning and competitor due out late next year.
     
  10. anonymous

    anonymous Guest


    That competitor will be out within weeks of drisa....FDA accepted the etep file. BMRN bet on the wrong horse with this one.
     
  11. anonymous

    anonymous Guest

    Looks like they got a neuro sales team ready for launch, but does anyone know if theyre expanding an MSL team? They can't possibly use their small existing rare dz team?
     
  12. anonymous

    anonymous Guest

    Yeah we wouldn't want an MSL to have to work 2 hrs a day rather than the usual 1! Such a grueling gig
     
  13. anonymous

    anonymous Guest

    I really hope that Biomarin is not planning on using their metabolic MSL for their Neuro launch! Very important launch, you need experienced and knowledgeable MSLs, even physicians, on the field. Don't screw this up!
     
  14. anonymous

    anonymous Guest

    not worth it
     
  15. anonymous

    anonymous Guest

  16. anonymous

    anonymous Guest

     
  17. anonymous

    anonymous Guest

    FDA will not approve drug.
     
  18. anonymous

    anonymous Guest

    A non-approval could not be happening to a nicer bunch of arrogant, egotistical, self absorbed, non-self aware, conceded bunch of pricks (at least the folks who I have met). Sorry for the patients but happy for the commercial folks who I have interacted with over the years.
     
  19. anonymous

    anonymous Guest

    Signed,
    An Unemployed Neuro MSL
     
  20. anonymous

    anonymous Guest

    Signed,

    A Sales rep who quit his job to take this big- talk job at Biomarin, got all cocky, only to have the drug not approved, so bye bye job, and bye bye cocky rep.